Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to assess whether hyperbaric oxygen treatment improves neurological function in patients who exhibit white matter hyperintensities on MRI examination. The seconda...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
St. Luke's Hospital, Chesterfield, Missouri
Collaborators
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT03624374 · Leukoencephalopathies, LBSL, and more
NCT06612736 · Neurological Impairments
NCT05750979 · LBSL, Leukoencephalopathies
NCT04988763 · Stroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitation
St. Luke's Hospital
Chesterfield, Missouri
Mallinckrodt Institute of Radiology/Washington University Medical School
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions